key
humor
regul
phosphat
homeostasi
involv
pathogenesi
human
diseas
human
fibroblast
growth
factor
becom
particularli
attract
therapeut
target
prepar
solubl
bioactiv
recombin
human
meet
increas
demand
pharmacolog
applic
small
ubiquitinrel
modifi
sumo
fusion
gene
nonfus
gene
amplifi
standard
pcr
method
clone
vector
transform
escherichia
coli
rosetta
best
combin
plasmid
host
strain
screen
rosetta
screen
protein
express
averag
bacteri
yield
solubl
express
level
recombin
three
batch
attain
g
respect
treatment
mm
h
fermentor
purifi
deae
sepharos
ff
nickel
nitrilotriacet
acid
affin
chromatographi
cleav
sumo
proteas
recombin
human
releas
fusion
protein
puriti
shown
high
perform
liquid
chromatographi
greater
yield
mgl
vitro
data
show
purifi
induc
phosphoryl
mitogenactiv
protein
kinas
glioma
cell
result
vivo
anim
experi
also
show
could
decreas
concentr
plasma
normal
rat
fed
fix
formula
diet
human
fibroblast
growth
factor
member
fgf
superfamili
first
identifi
yamashita
et
al
fulllength
consist
amino
acid
signal
peptid
amino
acid
nterminu
splice
matur
polypeptid
amino
acid
yamashita
et
al
reduc
serum
phosphat
inhibit
proxim
tubular
phosphat
reabsorpt
intestin
phosphat
absorpt
shimada
et
al
concern
physiolog
function
regul
phosphat
metabol
hand
mutat
implic
wide
rang
disord
autosom
domin
hypophosphatem
ricket
xlink
hypophosphatem
ricket
caus
excess
lead
hypophosphatemia
jonsson
et
al
yamazaki
et
al
level
increas
tenfold
control
patient
tumorinduc
osteomalacia
tumor
associ
syndrom
renal
phosphat
wast
jonsson
et
al
yamazaki
et
al
circul
level
also
increas
correl
diseas
burden
patient
fibrou
dysplasia
disord
normal
bone
replac
fibrooss
tissu
riminucci
et
al
reduc
signal
also
caus
patholog
famili
tumor
calcinosi
disord
mark
hyperphosphatemia
individu
develop
calcifi
mass
often
within
joint
lyle
et
al
addit
patient
chronic
kidney
diseas
ckd
concentr
elev
constitut
increas
progress
kidney
function
worsen
gutierrez
et
al
suggest
direct
link
increas
progress
ckd
fliser
et
al
given
import
role
physiolog
regul
phosphat
metabol
pharmacolog
signific
pathogenesi
human
diseas
next
step
necessari
prepar
suffici
activ
mechan
pharmacolog
research
yamashita
et
al
express
cho
mammalian
cell
well
known
mammalian
cell
express
system
complic
costli
standpoint
cultur
requir
make
strategi
difficult
use
develop
largescal
ferment
process
furthermor
prepar
suffici
amount
viru
largescal
express
time
consum
overcom
shortcom
plotnikov
et
al
express
escherichia
coli
form
inclus
bodi
howev
inclus
bodi
must
denatur
anneal
difficult
produc
bioactiv
protein
previou
experi
show
without
use
fusion
strategi
least
effect
express
solubl
properti
recent
year
small
ubiquitinrel
modifi
sumo
becom
effect
biotechnolog
tool
fusion
system
enhanc
solubl
express
protein
decreas
proteolyt
degrad
could
achiev
tradit
express
system
sun
et
al
sumo
posttransl
enzymat
cleav
desir
protein
sumo
ctermin
hydrolasesisopeptidas
variou
protein
sar
viru
protein
zuo
et
al
marbleston
et
al
egf
sun
et
al
metallothionein
wu
et
al
wang
et
al
express
success
purifi
use
fusion
strategi
thu
also
clone
sumo
fragment
construct
express
plasmidcontain
sumo
human
result
show
novel
method
protein
express
promot
significantli
greater
level
facilit
dissolut
solubl
fraction
purif
produc
nativ
ntermin
recombin
protein
bioactiv
preserv
primer
plasmid
strain
primer
synthes
chemic
beij
sunbiotech
co
ltd
china
puc
vector
contain
human
cdna
sequenc
genbank
access
number
express
protein
without
first
amino
acid
purchas
proteintech
group
inc
plasmid
strain
obtain
laboratori
engin
research
center
bioreactor
pharmaceut
develop
ministri
educ
jilin
agricultur
univers
china
e
coli
strain
use
host
clone
experi
protein
express
studi
perform
use
e
coli
strain
rosetta
host
vector
express
strain
use
optim
express
use
templat
sumo
gene
sumo
proteas
provid
dr
yadong
huang
jinan
univers
strategi
construct
four
kind
recombin
plasmid
illustr
fig
first
pcr
appli
amplifi
dna
fragment
encod
core
fragment
forward
fl
revers
primer
includ
bamh
site
use
puc
vector
accord
human
mrna
code
sequenc
sumo
fragment
ctermin
sequenc
five
primer
design
synthes
shown
fig
synthes
pcr
detail
step
provid
materi
method
contain
human
code
sequenc
templat
core
fragment
prepar
link
sumo
hand
fulllength
gene
without
fusion
sumo
creat
accord
procedur
describ
except
forward
primer
f
includ
nde
site
second
sumo
linker
gener
use
plasmidcontain
sumo
fragment
templat
p
includ
nde
site
sumo
linker
rl
forward
revers
primer
respect
use
sumo
linker
core
fragment
common
templat
p
includ
nde
site
primer
includ
bamh
site
forward
revers
primer
respect
fusion
gene
construct
creat
use
procedur
describ
third
fulllength
gene
fusion
gene
digest
ned
bamh
respect
ligat
previous
digest
creat
four
kind
new
express
vector
ie
correct
insert
sequenc
confirm
dna
sequenc
plasmid
four
kind
express
vector
construct
transform
compet
cell
strain
rosetta
transform
grown
luriabertani
lb
medium
contain
ampicillin
glucos
reach
iptg
ad
final
concentr
mm
cultur
incub
h
shake
rpm
express
cultur
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
express
level
determin
densitomet
scan
coloni
highest
express
level
use
subsequ
experi
analysi
perform
determin
effect
three
factor
iptg
concentr
temperatur
time
induct
express
yield
product
solubl
rosetta
recombin
bacteria
harvest
centrifug
g
min
cell
pellet
suspend
trishcl
buffer
concentr
mm
dissolv
sonic
suspens
centrifug
g
min
clear
supernat
solubl
fraction
collect
remain
pellet
insolubl
fraction
contain
inclus
bodi
resuspend
equal
volum
lysi
buffer
solubl
insolubl
fraction
analyz
sdspage
overnight
cultur
e
coli
strain
rosetta
transform
express
vector
contain
gene
dilut
l
growth
medium
lb
medium
contain
ampicillin
cultur
incub
optic
densiti
nm
protein
express
induc
addit
mm
iptg
h
addit
incub
cell
harvest
resuspend
mm
trishcl
buffer
contain
urea
sonic
result
cell
lysat
clear
bacteri
debri
ultracentrifug
fusion
protein
tag
ntermin
sumo
purifi
deae
sepharos
ff
column
chromatographi
flow
deae
column
bind
buffer
mm
urea
follow
purif
nickel
nitrilotriacet
acid
resin
ninta
invitrogen
ninta
resin
wash
bind
buffer
mm
urea
effluent
reach
baselin
condit
contamin
protein
elut
column
wash
buffer
mm
urea
contain
mm
imidazol
final
tag
protein
collect
column
elut
buffer
mm
urea
contain
mm
imidazol
sampl
taken
elut
peak
pool
puriti
assess
use
sdspage
concentr
evalu
bradford
method
remov
imidazol
urea
fusion
protein
obtain
affin
column
subject
buffer
chang
tb
use
dialysi
mm
tri
buffer
semiperm
membran
cutoff
da
result
protein
solut
treat
sumo
proteas
releas
recombin
standard
cleavag
reaction
fusion
protein
kda
digest
buffer
mm
trishcl
nacl
mm
dtt
incub
overnight
five
unit
sumo
proteas
provid
dr
yadong
huang
jinan
univers
result
cleavag
reaction
monitor
sdspage
target
protein
could
visual
convent
sdspage
purif
authent
assay
sumo
proteas
cleavag
reaction
mixtur
contain
tag
ntermin
sumo
target
protein
fusion
protein
sumo
proteas
reaction
mixtur
pass
miniatur
niimac
column
sumo
sumo
proteas
stay
bound
ninta
resin
flow
column
digest
buffer
product
desalt
sepharos
column
purifi
immunoblot
polyclon
mous
antibodi
santa
cruz
biotechnolog
inc
accord
manufactur
protocol
immunoreact
band
visual
use
dab
kit
boshid
inc
wuhan
china
furthermor
target
protein
identifi
matrixassist
laser
desorptionion
tandem
timeofflight
malditoftof
mass
spectrometri
analysi
technic
servic
provid
shanghai
appli
protein
technolog
co
ltd
high
perform
liquid
chromatographi
hplc
analysi
purifi
desalt
load
onto
column
elut
conduct
use
linear
gradient
acetonitril
flow
rate
mlmin
presenc
trifluoroacet
acid
fraction
contain
pool
concentr
evalu
bradford
method
vitro
activ
assay
assess
biolog
activ
protein
cellular
level
studi
abil
protein
activ
map
kinas
glioma
cell
line
express
abundantli
cognat
receptor
compar
commerci
also
express
e
coli
glioma
cell
cellsdish
serum
starv
h
stimul
ng
ml
commerci
ngml
pb
min
stimul
cell
lyse
cellular
protein
resolv
sdspolyacrylamid
gel
transfer
electrophoret
nitro
cellulos
membran
protein
blot
probe
antibodi
phosphoryl
map
kinas
nonphosphoryl
map
kinas
accord
manufactur
protocol
protein
level
perk
erk
examin
western
blot
actin
load
control
antibodi
santa
cruz
biotechnolog
vivo
activ
assay
describ
procedur
involv
anim
care
approv
institut
anim
care
use
committe
jilin
univers
perform
accord
institut
guidelin
anim
experi
wistar
adult
male
rat
weight
g
divid
randomli
three
group
treatment
group
control
group
commerci
neg
control
group
nc
salin
phosphatur
activ
examin
normal
rat
publish
protocol
goetz
et
al
briefli
anim
fed
complet
fixedformula
diet
contain
phosphat
week
fast
overnight
h
three
hour
inject
ml
blood
sampl
collect
tail
iv
administ
bodi
weight
either
commerci
salin
took
blood
sampl
h
phosphat
concentr
serum
determin
use
phosphomolybd
acid
detect
kit
nianj
jiangcheng
co
valu
express
mean
standard
error
mean
comparison
mean
valu
two
time
point
perform
use
student
test
signific
differ
consid
p
cell
assay
perform
triplic
experi
repeat
least
three
time
synthes
fulllength
fusion
gene
compos
sumo
core
fragment
five
special
primer
design
tabl
synthesi
strategi
describ
fig
detail
procedur
includ
materi
method
section
pcr
product
sumo
shown
fig
final
pcr
product
fulllength
digest
two
restrict
enzym
ned
bamh
clone
express
vector
respect
sequenc
target
gene
confirm
autom
dna
sequenc
result
pcr
product
show
sequenc
human
achiev
greater
product
perform
sever
smallscal
express
studi
experi
use
host
bacteria
rosetta
four
kind
recombin
plasmid
express
screen
result
show
except
combin
two
kind
plasmid
rosetta
host
strain
fig
combin
target
protein
express
chose
rosetta
optim
induct
condit
solubl
recombin
inocul
fresh
lb
medium
incub
shake
incub
iptg
ad
final
concentr
mm
h
induct
express
recombin
bacteri
cell
collect
centrifug
lyse
sonic
supernat
pellet
collect
analyz
use
sdspage
result
show
molecular
weight
express
product
kda
correspond
predict
size
target
protein
total
cellular
protein
solubl
fraction
much
total
express
recombin
protein
fig
concern
optim
cell
growth
condit
protein
product
screen
suitabl
iptg
concentr
temperatur
time
induct
express
yield
product
solubl
rosetta
found
lower
temperatur
lower
iptg
concentr
mm
longer
induct
h
express
protein
significantli
solubl
form
protein
fig
synthesi
pcr
strategi
synthes
describ
materi
method
molecular
weight
pcr
fragment
contain
sumo
shown
lane
sumo
fragment
bp
lane
fragment
bp
pcr
product
fusion
gene
shown
b
bp
length
result
show
rosetta
host
strain
transform
either
effect
target
protein
express
fusion
protein
molecular
mass
approxim
kda
correspond
predict
molecular
weight
protein
molecular
weight
marker
kilodalton
takara
lane
uninduc
induc
rosetta
respect
control
lane
uninduc
induc
rosetta
respect
lane
induc
rosetta
b
lane
precipit
supernat
rosetta
induc
mm
iptg
h
protein
molecular
weight
marker
kilodalton
fermenta
analysi
supernat
use
sdspage
show
solubl
express
h
total
supernat
protein
express
inclus
bodi
previou
experi
data
shown
accord
isoelectr
point
fusion
protein
deae
sepharos
ff
chosen
purif
small
amount
host
protein
remov
purifi
deae
sepharos
ff
column
except
host
dna
esm
fig
ninta
affin
column
chosen
purif
protein
without
tag
remov
ninta
resin
use
wash
buffer
contain
mm
imidazol
elut
use
elut
buffer
contain
mm
imidazol
sdspage
analysi
sampl
taken
step
show
puriti
reach
fig
sumo
proteas
recognit
sequenc
immedi
upstream
target
peptid
allow
latter
releas
fusion
sumo
without
leav
unwant
residu
upon
treatment
sumo
proteas
achiev
maxim
releas
protein
cleavag
reaction
perform
overnight
effici
cleavag
monitor
sdspage
slow
disappear
band
fusion
protein
kda
fig
observ
isol
recombin
cleavag
mixtur
character
western
blot
hplc
target
protein
fuse
directli
cterminu
sumo
cleavag
sumo
proteas
result
releas
target
protein
desir
ntermin
amino
acid
sequenc
studi
purifi
fusion
protein
dilut
cleav
sumo
proteas
cleavag
mixtur
purifi
ninta
resin
sumo
sumo
proteas
fusion
protein
contain
tag
affili
ninta
resin
flow
column
digest
buffer
result
show
highli
purifi
sdspage
fig
could
react
human
polyclon
antibodi
western
blot
fig
hplc
analysi
target
protein
show
major
peak
retent
time
min
puriti
exceed
fig
also
protein
success
identifi
malditoftof
detail
protein
list
esm
fig
test
activ
assay
stimul
glioma
cell
commerci
examin
whether
protein
induc
phosphoryl
mitogenactiv
protein
map
kinas
mapk
glioma
cell
illustr
fig
phosphoryl
mapk
activ
either
commerci
also
phosphoryl
erk
activ
compar
negativetr
group
commerci
activ
compar
negativetr
group
result
suggest
produc
sumo
fusion
method
better
biolog
activ
commerci
specul
commerci
may
fig
sdspage
analysi
purif
cleavag
recombin
bacteria
rosetta
treat
sonic
centrifug
supernat
load
deae
sepharos
ff
ninta
orderli
purif
result
shown
protein
molecular
weight
standard
kilodalton
fermenta
purifi
elut
ninta
column
purifi
digest
sumo
proteas
overnight
seen
b
cut
sumo
proteas
b
protein
molecular
weight
standard
kilodalton
takara
recombin
fusion
protein
tag
sumo
cleavag
product
respect
express
inclus
bodi
e
coli
form
fuse
sumo
evalu
biolog
activ
construct
rat
model
describ
materi
method
section
accord
refer
goetz
shimada
et
al
mice
administ
either
commerci
iv
experi
blood
sampl
collect
h
h
inject
plasma
level
phosphat
determin
phosphomolybd
acid
detect
kit
statist
result
describ
column
graph
shown
fig
see
comparison
phosphat
level
treatment
disclos
commerci
hypophosphatem
effect
h
compar
commerci
howev
afford
better
hypophosphatem
effect
fig
better
hypophosphatem
effect
commerci
consid
due
increas
bioactiv
produc
sumo
fusion
method
discoveri
reveal
regulatori
system
serum
phosphat
also
expand
spectrum
endocrin
diseas
necessari
develop
method
abund
product
specif
bioactiv
specif
treatment
diseas
futur
therefor
report
novel
strategi
express
purifi
recombin
greatli
experi
prove
least
effect
express
properti
unfus
protein
regardless
either
two
host
strain
data
shown
wherea
fuse
sumo
show
higher
amount
express
host
strain
rosetta
one
hand
sumo
chaperonelik
activ
translat
fusion
sumo
protein
often
result
significantli
improv
express
protein
e
coli
malakhov
et
al
marbleston
et
al
panava
et
al
zuo
et
al
hand
rosetta
strain
provid
addit
trna
e
coli
rare
codon
aua
agg
aga
cua
ccc
gga
therebi
increas
gene
express
taken
togeth
protein
effici
express
indispens
data
also
show
solubl
concentr
protein
optim
express
condit
induc
mm
iptg
h
compar
induc
mm
iptg
protein
express
inclus
bodi
data
shown
fact
lower
c
hplc
analysi
purifi
puriti
evalu
hplc
analysi
use
column
seen
chromatogram
yaxi
indic
absorb
xaxi
repres
elut
time
minut
main
peak
elut
min
puriti
purifi
greater
temperatur
lower
iptg
concentr
inde
make
protein
fold
significantli
deceler
increas
solubl
protein
level
addit
long
induct
period
also
necessari
purif
presenc
urea
denatur
solut
affin
ninta
significantli
alter
wherea
absenc
urea
well
solubl
solut
also
flew
nickel
column
previou
experi
prove
point
data
shown
specul
like
amino
acid
cover
six
histidin
site
sumo
tag
amino
acid
ad
urea
buffer
made
six
histidin
site
sumo
tag
expos
therebi
increas
affin
ninta
resin
system
humor
factor
renotrop
function
indic
kidney
may
bear
uniqu
receptor
specif
despit
previou
attempt
use
human
kidney
cell
line
phosphoryl
respons
well
observ
treatment
tri
glioma
cell
overexpress
evalu
biolog
activ
better
respons
obtain
seen
fig
although
case
absenc
klotho
receptor
recent
etiolog
studi
indic
high
level
associ
increas
mortal
cardiovascular
dysfunct
patient
ckd
also
subject
preserv
renal
function
juppner
et
al
shimada
et
al
whether
direct
action
cardiovascular
tissu
klotho
also
express
studi
cell
assay
strategi
good
answer
hypothesi
put
forward
mani
experi
document
reduc
serum
phosphat
mainli
two
mechan
inhibit
proxim
tubular
phosphat
reabsorpt
intestin
phosphat
absorpt
specif
explan
suppress
express
type
sodiumphosph
cotransport
mediat
physiolog
phosphat
reabsorpt
proxim
tubul
shimada
et
al
decreas
express
time
enhanc
express
shimada
et
al
modifi
express
vitamin
metabol
enzym
act
reduc
serum
oh
stimul
intestin
calcium
phosphat
absorpt
studi
also
see
chang
plasma
phosphat
level
show
signific
differ
either
inject
commerci
compar
fig
vitro
vivo
activ
assay
vitro
activ
assay
glioma
cell
line
treat
either
commerci
min
protein
level
phosphoryl
map
kinas
examin
western
blot
actin
load
control
valu
top
western
blot
repres
mean
optic
densiti
ratio
three
independ
experi
vs
neg
control
group
b
vivo
activ
assay
either
commerci
iv
administr
wistar
adult
male
rat
blood
sampl
collect
h
plasma
phosphat
concentr
measur
describ
materi
method
data
point
repres
p
p
vs
h
inject
p
vs
h
commerci
inject
bt
treatment
treatment
neg
control
administr
result
timedepend
better
reduct
circul
level
phosphat
commerci
specul
differ
effect
might
due
differ
express
form
e
coli
summari
success
express
e
coli
rosetta
fusion
gene
result
fusion
protein
could
cleav
sumo
proteas
give
free
isol
ninta
affin
column
ident
purifi
protein
confirm
western
blot
puriti
determin
hplc
analysi
recombin
induc
phosphoryl
map
kinas
mapk
glioma
cell
line
result
anim
experi
vivo
also
show
produc
use
method
decreas
concentr
plasma
phosphat
normal
rat
fed
fix
formula
diet
studi
demonstr
sumo
fuse
abl
promot
solubl
express
latter
e
coli
make
conveni
purifi
bioactiv
preserv
